Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-11

Clinical Trial Update: A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

Phase 3 trial of adalimumab in Japanese patients with active ankylosing spondylitis completed; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2010-08-11